{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:11:40Z","timestamp":1786990300708,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ijbiomac.2020.06.130","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T21:32:21Z","timestamp":1592429541000},"page":"1283-1292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Expression and characterization of a novel recombinant cytotoxin II from Naja naja oxiana venom: A potential treatment for breast cancer"],"prefix":"10.1016","volume":"162","author":[{"given":"Afshin","family":"Derakhshani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7814-7318","authenticated-orcid":false,"given":"Nicola","family":"Silvestris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4593-4803","authenticated-orcid":false,"given":"Khalil","family":"Hajiasgharzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mahmoudzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Fereidouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Virgilio","family":"Paradiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oronzo","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyhim","family":"Atarod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Safarpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8642-6795","authenticated-orcid":false,"given":"Behzad","family":"Baradaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijbiomac.2020.06.130_bb0005","first-page":"395","article-title":"Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence","volume":"159","author":"Li","year":"2016","journal-title":"treatment"},{"key":"10.1016\/j.ijbiomac.2020.06.130_bb0010","series-title":"Use of Statistics to Assess the Global Burden of Breast Cancer","first-page":"S70","volume":"12","author":"Parkin","year":"2006"},{"key":"10.1016\/j.ijbiomac.2020.06.130_bb0015","first-page":"S54","article-title":"Breast cancer in limited-resource countries: health care systems and public policy","volume":"12","author":"Anderson","year":"2006","journal-title":"P.P.P.J.T.b. J."},{"key":"10.1016\/j.ijbiomac.2020.06.130_bb0020","series-title":"Breast Cancer Treatment: A Review","first-page":"288","volume":"321","author":"Waks","year":"2019"},{"key":"10.1016\/j.ijbiomac.2020.06.130_bb0025","series-title":"Nanoparticle-mediated Targeted Drug Delivery for Breast Cancer Treatment","author":"Liyanage","year":"2019"},{"key":"10.1016\/j.ijbiomac.2020.06.130_bb0030","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3389\/fphar.2018.01300","article-title":"Evolution of cancer pharmacological treatments at the turn of the third millennium","volume":"9","author":"Falzone","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2020.06.130_bb0035","series-title":"Immunotherapy and Targeted Therapy Combinations in Metastatic Breast Cancer","first-page":"e175","volume":"20","author":"Esteva","year":"2019"},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.06.130_bb0040","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1002\/jcp.29216","article-title":"Overcoming trastuzumab resistance in HER2-positive breast cancer using combination therapy","volume":"235","author":"Derakhshani","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ijbiomac.2020.06.130_bb0045","first-page":"9","article-title":"Bispecific antibodies in cancer immunotherapy","volume":"65","author":"Rader","year":"2020"},{"key":"10.1016\/j.ijbiomac.2020.06.130_bb0050","series-title":"Oncolytic Viruses: Priming Time for Cancer Immunotherapy","first-page":"1","author":"Russell","year":"2019"},{"key":"10.1016\/j.ijbiomac.2020.06.130_bb0055","series-title":"Potential Drugs Used in the Antibody\u2013Drug Conjugate (ADC) Architecture for Cancer Therapy","first-page":"31","volume":"235","author":"Yaghoubi","year":"2020"},{"key":"10.1016\/j.ijbiomac.2020.06.130_bb0060","series-title":"Snake Venoms in Cancer Therapy: Past, Present and Future","first-page":"346","volume":"10","author":"Li","year":"2018"},{"key":"10.1016\/j.ijbiomac.2020.06.130_bb0065","series-title":"Therapeutic Potential of Venom Peptides","first-page":"790","volume":"2","author":"Lewis","year":"2003"},{"key":"10.1016\/j.ijbiomac.2020.06.130_bb0070","series-title":"Toxins From Venomous Animals: Gene Cloning, Protein Expression and Biotechnological Applications","first-page":"23","author":"Fernandes-Pedrosa","year":"2013"},{"key":"10.1016\/j.ijbiomac.2020.06.130_bb0075","series-title":"Animal Venoms Have Potential to Treat Cancer","first-page":"2555","volume":"18","author":"Chatterjee","year":"2018"},{"key":"10.1016\/j.ijbiomac.2020.06.130_bb0080","series-title":"Animal Toxins as Therapeutic Tools to Treat Neurodegenerative Diseases","first-page":"145","volume":"9","author":"de Souza","year":"2018"},{"key":"10.1016\/j.ijbiomac.2020.06.130_bb0085","series-title":"Antitumoral Activity of Snake Venom Proteins: New Trends in Cancer Therapy","volume":"2014","author":"Calderon","year":"2014"},{"key":"10.1016\/j.ijbiomac.2020.06.130_bb0090","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.toxicon.2016.12.001","article-title":"The small subunit of Hemilipin2, a new heterodimeric phospholipase A2 from Hemiscorpius lepturus scorpion venom, mediates the antiangiogenic effect of the whole protein","volume":"126","author":"Jridi","year":"2017","journal-title":"Toxicon"},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.06.130_bb0095","first-page":"1161","article-title":"Potential anticancer activity of Caspian cobra venom through induction of oxidative stress in glioblastoma cell line","volume":"89","author":"Sinaei","year":"2019","journal-title":"India Section B Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2020.06.130_bb0100","series-title":"Naja naja oxiana Venom Fraction Selectively Induces ROS-mediated Apoptosis in Human Colorectal Tumor Cells by Directly Targeting Mitochondria","first-page":"2201","volume":"18","author":"Fakhri","year":"2017"},{"key":"10.1016\/j.ijbiomac.2020.06.130_bb0105","series-title":"Cytotoxic Activity of NN-32 Toxin From Indian Spectacled Cobra Venom on Human Breast Cancer Cell Lines","first-page":"503","volume":"17","author":"Attarde","year":"2017"},{"key":"10.1016\/j.ijbiomac.2020.06.130_bb0110","series-title":"Central Asian Cobra Venom Cytotoxins-induced Aggregation, Permeability and Fusion of Liposomes","first-page":"459","volume":"8","author":"Aripov","year":"1989"},{"issue":"6","key":"10.1016\/j.ijbiomac.2020.06.130_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129248","article-title":"Naja naja oxiana Cobra venom cytotoxins CTI and CTII disrupt mitochondrial membrane integrity: implications for basic three-fingered cytotoxins","volume":"10","author":"Gasanov","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.06.130_bb0120","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4048\/jbc.2014.17.4.314","article-title":"Anticancer activity of cobra venom polypeptide, cytotoxin-II, against human breast adenocarcinoma cell line (MCF-7) via the induction of apoptosis","volume":"17","author":"Ebrahim","year":"2014","journal-title":"J. Breast Cancer"},{"issue":"8","key":"10.1016\/j.ijbiomac.2020.06.130_bb0125","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1016\/j.clinthera.2017.05.223","article-title":"Cytotoxic activity of NN-32 toxin from Indian spectacled cobra venom on human breast cancer cell line","volume":"39","author":"Attarde","year":"2017","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ijbiomac.2020.06.130_bb0130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijbiomac.2019.07.078","article-title":"Optimization of induction parameters, structure quality assessment by ATR-FTIR and in silico characterization of expressed recombinant polcalcin in three different strains of Escherichia coli","volume":"138","author":"Derakhshani","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.06.130_bb0135","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.pep.2010.03.022","article-title":"Recombinant production of bioactive human TNF-alpha by SUMO-fusion system--high yields from shake-flask culture","volume":"72","author":"Hoffmann","year":"2010","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ijbiomac.2020.06.130_bb0140","series-title":"Optical Spectroscopy to Characterize Protein Conformation and Conformational Changes","first-page":"11","author":"Schmid","year":"1997"},{"key":"10.1016\/j.ijbiomac.2020.06.130_bb0145","series-title":"SUMO protocols","first-page":"303","article-title":"SUMO fusion technology for enhanced protein production in prokaryotic and eukaryotic expression systems","author":"Panavas","year":"2009"},{"key":"10.1016\/j.ijbiomac.2020.06.130_bb0150","series-title":"High-yield Expression in Escherichia coli, Biophysical Characterization, and Biological Evaluation of Plant Toxin Gelonin","first-page":"19","volume":"9","author":"Ding","year":"2019"},{"key":"10.1016\/j.ijbiomac.2020.06.130_bb0155","series-title":"Characterising the Secondary Structure Changes Occurring in High Density Systems of BLG Dissolved in Aqueous pH 3 Buffer","first-page":"216","volume":"46","author":"Ioannou","year":"2015"},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.06.130_bb0160","first-page":"233","article-title":"Scorpion and spider venoms in cancer treatment: state of the art, challenges, and perspectives","volume":"3","author":"Rap\u00f4so","year":"2017","journal-title":"J. Clin. Transl. Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2020.06.130_bb0165","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S1357-2725(97)00024-1","article-title":"Characterization and cytotoxicity of L-amino acid oxidase from the venom of king cobra (Ophiophagus hannah)","volume":"29","author":"Ahn","year":"1997","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"13","key":"10.1016\/j.ijbiomac.2020.06.130_bb0170","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.lfs.2006.12.024","article-title":"ACTX-8, a cytotoxic L-amino acid oxidase isolated from Agkistrodon acutus snake venom, induces apoptosis in Hela cervical cancer cells","volume":"80","author":"Zhang","year":"2007","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.06.130_bb0175","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.toxicon.2010.05.016","article-title":"A lethal cardiotoxic-cytotoxic protein from the Indian monocellate cobra (Naja kaouthia) venom","volume":"56","author":"Debnath","year":"2010","journal-title":"Toxicon"},{"issue":"7","key":"10.1016\/j.ijbiomac.2020.06.130_bb0180","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.toxicon.2011.04.012","article-title":"Cytotoxic and antioxidant property of a purified fraction (NN-32) of Indian Naja naja venom on Ehrlich ascites carcinoma in BALB\/c mice","volume":"57","author":"Das","year":"2011","journal-title":"Toxicon"},{"issue":"Suppl","key":"10.1016\/j.ijbiomac.2020.06.130_bb0185","first-page":"101","article-title":"Anticancer activity a of Caspian cobra (Naja Naja oxiana) snake venom in human cancer cell lines via induction of apoptosis","volume":"15","author":"Ebrahim","year":"2016","journal-title":"Iran. J. Pharm. Res."},{"issue":"8","key":"10.1016\/j.ijbiomac.2020.06.130_bb0190","first-page":"2201","article-title":"Naja naja oxiana venom fraction selectively induces ROS-mediated apoptosis in human colorectal tumor cells by directly targeting mitochondria","volume":"18","author":"Fakhri","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"6","key":"10.1016\/j.ijbiomac.2020.06.130_bb0200","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1038\/nprot.2006.202","article-title":"Using circular dichroism spectra to estimate protein secondary structure","volume":"1","author":"Greenfield","year":"2006","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.06.130_bb0205","doi-asserted-by":"crossref","first-page":"205","DOI":"10.15171\/apb.2019.024","article-title":"Understanding apoptosis and apoptotic pathways targeted cancer therapeutics","volume":"9","author":"Jan","year":"2019","journal-title":"Adv. Pharm. Bull."},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.06.130_bb0210","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/emm.2006.51","article-title":"Up-regulation of Bax and endonuclease G, and down-modulation of Bcl-X L involved in cardiotoxin III-induced apoptosis in K562 cells","volume":"38","author":"Yang","year":"2006","journal-title":"Exp. Mol. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2020.06.130_bb0215","doi-asserted-by":"crossref","first-page":"652","DOI":"10.2174\/1567201811666140515101130","article-title":"Influence of gold nanoparticle tagged snake venom protein toxin NKCT1 on Ehrlich ascites carcinoma (EAC) and EAC induced solid tumor bearing male albino mice","volume":"11","author":"Bhowmik","year":"2014","journal-title":"Curr. Drug Deliv."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813020335728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813020335728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:26:13Z","timestamp":1758875173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813020335728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":42,"alternative-id":["S0141813020335728"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.06.130","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression and characterization of a novel recombinant cytotoxin II from Naja naja oxiana venom: A potential treatment for breast cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.06.130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}